Abstract
Purpose of review
Integrating palliative care in the management of patients with advanced liver disease is a growing area of interest in hepatology. This review will provide practical updates based on recent literature, rectify common misunderstandings, and help clinicians learn facts they can apply in their routine practice to offer their patients the benefits of palliative care.
Recent findings
Compelling data proves the need and benefits of using palliative care for patients with cirrhosis and/or liver cancer, including those waiting for liver transplantation. This additional layer of supportive care for patients and their caregivers has a positive impact on symptoms, quality of life, and clarification of goals of care.
Summary
Despite evidence showing the importance of palliative care in the management of advanced liver disease, several misconceptions remain. Ongoing and future research will hopefully answer questions on best delivery modes and benefits of palliative care for different patient populations, while also exploring the impact for caregivers and medical providers.
Similar content being viewed by others
References and Recommended Readings
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
•• Fricker ZP, Serper M. Current knowledge, barriers to implementation, and future directions in palliative care for end-stage liver disease. Liver Transpl. 2019;25:787–96 This review is a comprehensive analysis of the latest studies of palliative care in cirrhosis.
Ferrell BR, Twaddle ML, Melnick A, et al. National consensus project clinical practice guidelines for quality palliative care guidelines, 4th Edition. J Palliat Med. 2018; This is a landmark document about palliative care, constantly updated to ensure excellence in the delivery of palliative care.
Kelly SG, Campbell TC, Hillman L, et al. The utilization of palliative care services in patients with cirrhosis who have been denied liver transplantation: a single center retrospective review. Ann Hepatol. 2017;16:395–401.
Shinall MC Jr, Karlekar M, Martin S, et al. COMPASS: a pilot trial of an early palliative care intervention for patients with end-stage liver disease. J Pain Symptom Manage. 2019;58:614–622.e3.
Ufere NN, O’Riordan DL, Bischoff KE, Marks AK, Eneanya N, Chung RT, et al. Outcomes of palliative care consultations for hospitalized patients with liver disease. J Pain Symptom Manag. 2019;58:766–73.
Mudumbi SK, Bourgeois CE, Hoppman NA, Smith CH, Verma M, Bakitas MA, et al. Palliative care and hospice interventions in decompensated cirrhosis and hepatocellular carcinoma: a rapid review of literature. J Palliat Med. 2018;21:1177–84.
Patel AA, Walling AM, Ricks-Oddie J, et al. Palliative care and health care utilization for patients with end-stage liver disease at the end of life. Clin Gastroenterol Hepatol. 2017;15:1612–1619.e4.
Carbonneau M, Davyduke T, Spiers J, et al. Patient views on advance care planning in cirrhosis: a qualitative analysis. Can J Gastroenterol Hepatol. 2018;2018:4040518.
Sprange A, Ismond KP, Hjartarson E, et al. Advance care planning preferences and readiness in cirrhosis: a prospective assessment of patient perceptions and knowledge. J Palliat Med. 2019.
Baumann AJ, Wheeler DS, James M, et al. Benefit of early palliative care intervention in end-stage liver disease patients awaiting liver transplantation. J Pain Symptom Manag. 2015;50:882–6 e2.
Kathpalia P, Smith A, Lai JC. Underutilization of palliative care services in the liver transplant population. World J Transplant. 2016;6:594–8.
Walling AM, Asch SM, Lorenz KA, Wenger NS. Impact of consideration of transplantation on end-of-life care for patients during a terminal hospitalization. Transplantation. 2013;95:641–6.
Walling AM, Schreibeis-Baum H, Pimstone N, et al. Proactive case finding to improve concurrently curative and palliative care in patients with end-stage liver disease. J Palliat Med. 2015;18:378–81.
Wentlandt K, Dall’Osto A, Freeman N, et al. The transplant palliative care clinic: an early palliative care model for patients in a transplant program. Clin Transpl. 2016;30:1591–6.
•• Wentlandt K, Weiss A, O’Connor E, et al. Palliative and end of life care in solid organ transplantation. Am J Transplant. 2017;17:3008–19 This review summarizes existing research supporting palliative intervention in advanced organ failure and transplant populations, also introduces a model to provide palliative care in parallel with disease-directed therapy in a transplant program.
•• Brisebois A, Ismond KP, Carbonneau M, et al. Advance care planning (ACP) for specialists managing cirrhosis: a focus on patient-centered care. Hepatology. 2018;67:2025–40 This is the best review for providers who take care of patients with cirrhosis to become proficient in discussing advance care planning.
Low J, Davis S, Vickerstaff V, et al. Advanced chronic liver disease in the last year of life: a mixed methods study to understand how care in a specialist liver unit could be improved. BMJ Open. 2017;7:e016887.
Low JTS, Rohde G, Pittordou K, Candy B, Davis S, Marshall A, et al. Supportive and palliative care in people with cirrhosis: international systematic review of the perspective of patients, family members and health professionals. J Hepatol. 2018;69:1260–73.
Ufere NN, Donlan J, Waldman L, Dienstag JL, Friedman LS, Corey KE, et al. Barriers to use of palliative care and advance care planning discussions for patients with end-stage liver disease. Clin Gastroenterol Hepatol. 2019;17:2592–9.
• Woodrell CD, Hansen L, Schiano TD, et al. Palliative care for people with hepatocellular carcinoma, and specific benefits for older adults. Clin Ther. 2018;40:512–25 This is a practical review on integrating palliative care in the management of patients with liver cancer.
Beck KR, Pantilat SZ, O’Riordan DL, Peters MG. Use of palliative care consultation for patients with end-stage liver disease: survey of liver transplant service providers. J Palliat Med. 2016;19:836–41.
Esteban JPG, Rein L, Szabo A, et al. Attitudes of liver and palliative care clinicians toward specialist palliative care consultation for patients with end-stage liver disease. J Palliat Med. 2019;22:804–13.
Kimbell B, Boyd K, Kendall M, et al. Managing uncertainty in advanced liver disease: a qualitative, multiperspective, serial interview study. BMJ Open. 2015;5:e009241.
Peng JK, Hepgul N, Higginson IJ, Gao W. Symptom prevalence and quality of life of patients with end-stage liver disease: a systematic review and meta-analysis. Palliat Med. 2019;33:24–36.
Poonja Z, Brisebois A, van Zanten SV, et al. Patients with cirrhosis and denied liver transplants rarely receive adequate palliative care or appropriate management. Clin Gastroenterol Hepatol. 2014;12:692–8.
Ufere NN, Brahmania M, Sey M, Teriaky A, el-Jawahri A, Walley KR, et al. Outcomes of in-hospital cardiopulmonary resuscitation for patients with end-stage liver disease. Liver Int. 2019;39:1256–62.
Ufere NN, Halford JL, Caldwell J, et al. Health care utilization and end-of-life care outcomes for patients with decompensated cirrhosis based on transplant candidacy. J Pain Symptom Manag. 2019.
Kavalieratos D, Corbelli J, Zhang D, Dionne-Odom JN, Ernecoff NC, Hanmer J, et al. Association between palliative care and patient and caregiver outcomes: a systematic review and meta-analysis. JAMA. 2016;316:2104–14.
• Walling AM, Ahluwalia SC, Wenger NS, et al. Palliative care quality indicators for patients with end-stage liver disease due to cirrhosis. Dig Dis Sci. 2017;62:84–92 This is a set of proposed quality indicators for palliative care in cirrhosis.
Ufere NN, Donlan J, Waldman L, Patel A, Dienstag JL, Friedman LS, et al. Physicians’ perspectives on palliative care for patients with end-stage liver disease: a national survey study. liver transpl. 2019;25:859–69.
Downar J. Resources for educating, training, and mentoring all physicians providing palliative care. J Palliat Med. 2018;21:S57–62.
Rakoski MO, Volk ML. Palliative care and end-stage liver disease: a critical review of current knowledge. Curr Opin Gastroenterol. 2019;35:155–60.
Langberg KM, Kapo JM, Taddei TH. Palliative care in decompensated cirrhosis: a review. Liver Int. 2018;38:768–75.
•• Verma M, Kosinski AS, Volk ML, et al. Introducing palliative care within the treatment of end-stage liver disease: the study protocol of a cluster randomized controlled trial. J Palliat Med. 2019;22:34–43 This is a description of an innovative prospective multicenter cluster randomized trial investigating palliative care delivery within routine outpatient care for patients with end-stage liver disease.
Brown E, Morrison RS, Gelfman LP. An update: NIH research funding for palliative medicine, 2011-2015. J Palliat Med. 2018;21:182–7.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Jakab SS declares that she has no conflict of interest. Verma M declares that she has no conflict of interest. Navarro V declares that he has no conflict of interest. Taddei TH declares that she has no conflict of interest.
The authors are investigators in a clinical trial supported by a Patient-Centered Outcomes Research Institute (PCORI) Award (PLC-1609-36714).
Disclaimer
The statements in this article are solely the responsibility of the authors and do not necessarily represent the views of the Patient-Centered Outcomes Research Institute (PCORI), its Board of Governors, or Methodology Committee.
Human and animal rights and informed consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Liver
Rights and permissions
About this article
Cite this article
Jakab, S.S., Verma, M., Navarro, V. et al. Palliative Care in Cirrhosis: Beyond Misconceptions. Curr Treat Options Gastro 18, 245–254 (2020). https://doi.org/10.1007/s11938-020-00283-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11938-020-00283-1